Advancing Wearable Biosensors for Congenital Heart Disease: Patient and Clinician Perspectives: A Science Advisory from the American Heart Association

Animesh Tandon, Jennifer N. Avari Silva, Ami B. Bhatt, Colin K. Drummond, Allison C. Hill, Amanda E. Paluch, Sheradon Waits, Jenny E. Zablah, Kevin C. Harris

Research output: Contribution to journalReview articlepeer-review

Abstract

Wearable biosensors (wearables) enable continual, noninvasive physiologic and behavioral monitoring at home for those with pediatric or congenital heart disease. Wearables allow patients to access their personal data and monitor their health. Despite substantial technologic advances in recent years, issues with hardware design, data analysis, and integration into the clinical workflow prevent wearables from reaching their potential in high-risk congenital heart disease populations. This science advisory reviews the use of wearables in patients with congenital heart disease, how to improve these technologies for clinicians and patients, and ethical and regulatory considerations. Challenges related to the use of wearables are common to every clinical setting, but specific topics for consideration in congenital heart disease are highlighted.

Original languageEnglish
Pages (from-to)E1134-E1142
JournalCirculation
Volume149
Issue number19
DOIs
StatePublished - May 7 2024

Keywords

  • AHA Scientific Statements
  • behavior
  • biosensing techniques
  • heart defects, congenital
  • monitoring, physiologic
  • wearable electronic devices

Fingerprint

Dive into the research topics of 'Advancing Wearable Biosensors for Congenital Heart Disease: Patient and Clinician Perspectives: A Science Advisory from the American Heart Association'. Together they form a unique fingerprint.

Cite this